IMMUNE MARKERS IN SURGICALLY RESECTED EARLY STAGE NON-SMALL CELL LUNG CANCER PATIENTS

UYSAL P., Kilic B., DEMİRKAYA A., Afsar C. U., Karaca F.

ACTA MEDICA MEDITERRANEA, cilt.35, sa.1, ss.65-69, 2019 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 35 Sayı: 1
  • Basım Tarihi: 2019
  • Doi Numarası: 10.19193/0393-6384_2019_1_11
  • Dergi Adı: ACTA MEDICA MEDITERRANEA
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.65-69
  • Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Evet

Özet

Purpose: Non-small cell lung cancer (NSCLC) is the most common cancer and the leading cause of cancer-related deaths worldwide. Inflammatory markers, such as C-reactive protein (CRP), neutrophil-lymphocyte ratio (NLR), lymphocyte-monocyte ratio and platelet-lymphocyte ratio (PLR), serve as indexes for the immune status of the host and the degree of tumor progression. In this study, we evaluated NLR and PLR values in early stage lung cancer patients before and after surgery and its correlation with clinical variables and survival.